Prevalence of restless legs syndrome among adults in Iceland and Sweden: Lung function, comorbidity, ferritin, biomarkers and quality of life

被引:105
作者
Benediktsdottir, Bryndis [1 ,3 ]
Janson, Christer [2 ]
Lindberg, Eva [2 ]
Arnardottir, Erna Sif [1 ,3 ]
Olafsson, Isleifur [4 ]
Cook, Elizabeth [4 ]
Thorarinsdottir, Elin Helga [1 ]
Gislason, Thorarinn [1 ,3 ]
机构
[1] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland
[2] Uppsala Univ, Uppsala, Sweden
[3] Landspitali Univ Hosp, Dept Resp Med & Sleep, IS-108 Reykjavik, Iceland
[4] Landspitali Univ Hosp, Dept Clin Biochem, IS-108 Reykjavik, Iceland
关键词
Restless legs syndrome; Epidemiology; Ferritin; CRP; IL-6; Lung function; Hypertension; Quality of life; OBSTRUCTIVE PULMONARY-DISEASE; IRON STATUS; GENERAL-POPULATION; SLEEP COMPLAINTS; PRIMARY-CARE; RISK-FACTORS; SYNDROME RLS; EPIDEMIOLOGY; DIAGNOSIS; SYMPTOMS;
D O I
10.1016/j.sleep.2010.08.006
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: This study investigates the prevalence and the association between restless legs syndrome (RLS) and a large variety of health variables in two well-characterized random samples from the general population in Reykjavik, Iceland, and Uppsala, Sweden. Methods: Using the national registries of inhabitants, a random sample from adults aged 40 and over living in Reykjavik, Iceland (n = 939), and Uppsala, Sweden (n = 998), were invited to participate in a study on the prevalence of COPD (response rate 81.1% and 62.2%). In addition, the participants were asked to answer the following questionnaires: International RLS Rating Scale, Short Form-12, the Epworth Sleepiness Scale, and questions about sleep, gastroeosophageal reflux, diabetes and hypertension, as well as pharmacological treatment. Interleukin-6 (IL-6), C-reactive protein (CRP) and ferritin were measured in serum. Results: RLS was more commonly reported in Reykjavik (18.3%) than in Uppsala (11.5%). Icelandic women reported RLS almost twice as often as Swedish women (24.4 vs. 13.9% p = 0.001), but there was no difference in prevalence of RLS between Icelandic and Swedish men. RLS was strongly associated with sleep disturbances and excessive daytime sleepiness. Subjects with RLS were more likely to be ex- and current smokers than subjects without RLS (p < 0.001). Respiratory symptoms and airway obstruction were more prevalent among those reporting RLS and they also estimated their physical quality of life lower than those without RLS (p < 0.001). RLS was not associated with symptoms of the metabolic syndrome like hypertension, obesity, markers of systemic inflammation (IL-6 and CRP) or cardiovascular diseases. Ferritin levels were significantly lower in RLS participants (p = 0.0002), but not (p = 0.07) after adjustment for center, age, sex and smoking history. Conclusion: Restless legs syndrome was twice as common among Icelandic women compared to Swedish women. No such difference was seen for men. RLS was strongly associated with smoking and respiratory symptoms, decreased lung function, sleep disturbances, excessive daytime sleepiness, and physical aspects of life quality. RLS was not associated with markers of the metabolic syndrome like hypertension, obesity, cardiovascular diseases or biomarkers of systemic inflammation. (C) 2010 Elsevier B.V. All rights reserved.
引用
收藏
页码:1043 / 1048
页数:6
相关论文
共 35 条
[1]   Dopamine and iron in the pathophysiology of restless legs syndrome (RLS) [J].
Allen, R .
SLEEP MEDICINE, 2004, 5 (04) :385-391
[2]   Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology - A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health [J].
Allen, RP ;
Picchietti, D ;
Hening, WA ;
Trenkwalder, C ;
Walters, AS ;
Montplaisi, J .
SLEEP MEDICINE, 2003, 4 (02) :101-119
[3]   Restless legs syndrome prevalence and impact - REST general population study [J].
Allen, RP ;
Walters, AS ;
Montplaisir, J ;
Hening, W ;
Myers, A ;
Bell, TJ ;
Ferini-Strambi, L .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (11) :1286-1292
[4]   Systemic manifestations and comorbidities of COPD [J].
Barnes, P. J. ;
Celli, B. R. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 33 (05) :1165-1185
[5]   Iron status and neural functioning [J].
Beard, JL ;
Connor, JR .
ANNUAL REVIEW OF NUTRITION, 2003, 23 :41-58
[6]   Sex and the risk of restless legs syndrome in the general population [J].
Berger, K ;
Luedemann, J ;
Trenkwalder, C ;
Ulrich, J ;
Kessler, C .
ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (02) :196-202
[7]   Prevalence, severity and risk factors of restless legs syndrome in the general adult population in two Scandinavian countries [J].
Bjorvatn, B ;
Leissner, L ;
Ulfberg, J ;
Gyring, J ;
Karlsborg, M ;
Regeur, L ;
Skeidsvoll, H ;
Nordhus, IH ;
Pallesen, S .
SLEEP MEDICINE, 2005, 6 (04) :307-312
[8]   Iron status among 3005 women aged 20-55 years in central Norway:: The Nord-Trondelag Health study (the HUNT study) [J].
Borch-Iohnsen, B ;
Sandstad, B ;
Åsberg, A .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2005, 65 (01) :45-54
[9]   Antidepressant medication use and restless legs syndrome in patients presenting with insomnia [J].
Brown, LK ;
Dedrick, DL ;
Doggett, JW ;
Guido, PS .
SLEEP MEDICINE, 2005, 6 (05) :443-450
[10]   International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study [J].
Buist, A. Sonia ;
McBurnie, Mary Ann ;
Vollmer, William M. ;
Gillespie, Suzanne ;
Burney, Peter ;
Mannino, David M. ;
Menezes, Ana M. B. ;
Sullivan, Sean D. ;
Lee, Todd A. ;
Weiss, Kevin B. ;
Jensen, Robert L. ;
Marks, Guy B. ;
Gulsvik, Amund ;
Nizankowska-Mogilnicka, Ewa .
LANCET, 2007, 370 (9589) :741-750